NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
12 hedge funds and large institutions have $858K invested in NexImmune, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
274% more capital invested
Capital invested by funds: $229K → $858K (+$629K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$461K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$92.5K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$83.2K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$316 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$71.2K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6.73K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.7K |
| 4 |
Morgan Stanley
New York
|
-$76 |
| 5 |
BlackRock
New York
|
-$31 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $336K | +$461K | +59,851 | New |
|
|
SPC
2
Slate Path Capital
New York
| $208K | – | – | – |
|
|
ECG
3
EPIQ Capital Group
San Francisco,
California
| $87.7K | – | – | – |
|
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $70.9K | – | – | – |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $67.4K | +$92.5K | +12,010 | New |
|
|
RJA
6
Raymond James & Associates
St Petersburg,
Florida
| $60.6K | +$83.2K | +10,804 | New |
|
7
Comerica Bank
Dallas,
Texas
| $18.3K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $8.86K | -$1.7K | -221 | -12% |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | -$6.73K | -874 | -83% |
|
|
10
BNP Paribas Financial Markets
Paris,
France
| $230 | +$316 | +41 | New |
|
|
11
Wells Fargo
San Francisco,
California
| $39 | +$15 | +2 | +40% |
|
12
UBS Group
Zurich,
Switzerland
| $6 | – | – | – |
|
|
13
Adage Capital Partners
Boston,
Massachusetts
| – | -$71.2K | -32,054 | Closed |
|
|
14
Morgan Stanley
New York
| – | -$76 | -34 | Closed |
|
|
15
BlackRock
New York
| – | -$31 | -14 | Closed |
|
NEXI Hedge Fund Activity: Q1 2024 in Review
12 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q1 2024, worth a combined $858K — up 274% from $229K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NEXI positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $461K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $71.2K sold.
- 12 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q1 2024, up from 11 in Q4 2023.
- Funds reported $858K of NexImmune, Inc. Common Stock stock for Q1 2024, up 274% quarter-over-quarter.
- 4 funds opened new NexImmune, Inc. Common Stock positions in Q1 2024 and 3 closed out, a net change of +1 holder.
- The largest NexImmune, Inc. Common Stock buyer in Q1 2024 was Sabby Management, an estimated $461K added.
- The largest NexImmune, Inc. Common Stock seller in Q1 2024 was Adage Capital Partners, an estimated $71.2K sold.
Based on aggregated 13F filings for Q1 2024.